Movement Disorders Associated with the Use of Gabapentin
- 1 October 1996
- Vol. 37 (10) , 988-990
- https://doi.org/10.1111/j.1528-1157.1996.tb00537.x
Abstract
We report two cases of unusual movement disorders associated with the use of gabapentin (GBP) in patients being treated for epilepsy who were otherwise neurologically intact. We describe two cases of unusual movement disorders associated with the use of GBP. There were significant differences in the clinical findings between the two cases. In the first case, movements were very pronounced and the patient was in oculogyric crisis. Movements in the second case were quite subtle but nonetheless problematic for the patient. In each case, discontinuation of GBP led to rapid resolution of the movements, although a single dose of lorazepam was used in the first case. Although formal electrophysiologic studies have not been performed, the movements associated with GBP use appear to be dystonic or myoclonic. Discontinuation of GBP led to rapid resolution of the movements. In severe cases, as in patients with oculogyric crisis, small doses of a benzodiazepine (BZD) appear to be efficacious and safe.Keywords
This publication has 11 references indexed in Scilit:
- GabapentinEpilepsia, 1995
- Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysateEpilepsy Research, 1993
- Acute Dystonic Reaction in Normal Humans Caused by Catecholamine DepletionClinical Neuropharmacology, 1990
- Adverse Neuropsychiatric Effects of Anticonvulsant DrugsDrugs, 1985
- Focal Dystonic Reaction to PhenytoinDevelopmental Medicine and Child Neurology, 1984
- Phenytoin‐induced dystoniaAnnals of Neurology, 1983
- Efficacy of a combination of sodium valproate and baclofen in Meige's disease (idiopathic orofacial dystonia).BMJ, 1982
- Valproate tremorsNeurology, 1982
- Tremor due to sodium valproateNeurology, 1979
- Severe bradykinesia as a manifestation of toxicity to antiepileptic medicationsThe Journal of Pediatrics, 1971